Synthesis of 4′-Ethynyl-2′-deoxy-4′-thioribonucleosides and Discovery of a Highly Potent and Less Toxic NRTI
Identifieur interne : 001372 ( Main/Curation ); précédent : 001371; suivant : 001373Synthesis of 4′-Ethynyl-2′-deoxy-4′-thioribonucleosides and Discovery of a Highly Potent and Less Toxic NRTI
Auteurs : Kazuhiro Haraguchi [Japon] ; Hisashi Shimada [Japon] ; Keigo Kimura [Japon] ; Genta Akutsu [Japon] ; Hiromichi Tanaka [Japon] ; Hiroshi Abe [Japon] ; Takayuki Hamasaki [Japon] ; Masanori Baba [Japon] ; Elizabeth A. Gullen [États-Unis] ; Ginger E. Dutschman [États-Unis] ; Yung-Chi Cheng [États-Unis] ; Jan Balzarini [Belgique]Source :
- ACS Medicinal Chemistry Letters [ 1948-5875 ] ; 2011.
Abstract
The synthesis of 4′-ethynyl-2′-deoxy-4′-thioribonucleosides was carried out utilizing an electrophilic glycosidation in which 4-ethynyl-4-thiofuranoid glycal
Url:
DOI: 10.1021/ml2001054
PubMed: 23795238
PubMed Central: 3686520
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000057
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000057
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000779
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000387
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000387
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000387
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :001374
Links to Exploration step
PMC:3686520Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Synthesis of 4′-Ethynyl-2′-deoxy-4′-thioribonucleosides and Discovery of a Highly Potent and Less Toxic NRTI</title>
<author><name sortKey="Haraguchi, Kazuhiro" sort="Haraguchi, Kazuhiro" uniqKey="Haraguchi K" first="Kazuhiro" last="Haraguchi">Kazuhiro Haraguchi</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">School of Pharmacy,<institution>Showa University</institution>
, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shimada, Hisashi" sort="Shimada, Hisashi" uniqKey="Shimada H" first="Hisashi" last="Shimada">Hisashi Shimada</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">School of Pharmacy,<institution>Showa University</institution>
, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kimura, Keigo" sort="Kimura, Keigo" uniqKey="Kimura K" first="Keigo" last="Kimura">Keigo Kimura</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">School of Pharmacy,<institution>Showa University</institution>
, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Akutsu, Genta" sort="Akutsu, Genta" uniqKey="Akutsu G" first="Genta" last="Akutsu">Genta Akutsu</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">School of Pharmacy,<institution>Showa University</institution>
, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tanaka, Hiromichi" sort="Tanaka, Hiromichi" uniqKey="Tanaka H" first="Hiromichi" last="Tanaka">Hiromichi Tanaka</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">School of Pharmacy,<institution>Showa University</institution>
, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Abe, Hiroshi" sort="Abe, Hiroshi" uniqKey="Abe H" first="Hiroshi" last="Abe">Hiroshi Abe</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">RIKEN Advanced Science Institute,<institution>Nanomedical Engineering Laboratory</institution>
, 2-1, Hirosawa, Wako-shi, Saitama 351-0198, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 2-1, Hirosawa, Wako-shi, Saitama 351-0198</wicri:regionArea>
<wicri:noRegion>Saitama 351-0198</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hamasaki, Takayuki" sort="Hamasaki, Takayuki" uniqKey="Hamasaki T" first="Takayuki" last="Hamasaki">Takayuki Hamasaki</name>
<affiliation wicri:level="1"><nlm:aff id="aff3">Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences,<institution>Kagoshima University</institution>
, Kagoshima 89-8544, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, Kagoshima 89-8544</wicri:regionArea>
<wicri:noRegion>Kagoshima 89-8544</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baba, Masanori" sort="Baba, Masanori" uniqKey="Baba M" first="Masanori" last="Baba">Masanori Baba</name>
<affiliation wicri:level="1"><nlm:aff id="aff3">Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences,<institution>Kagoshima University</institution>
, Kagoshima 89-8544, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, Kagoshima 89-8544</wicri:regionArea>
<wicri:noRegion>Kagoshima 89-8544</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gullen, Elizabeth A" sort="Gullen, Elizabeth A" uniqKey="Gullen E" first="Elizabeth A." last="Gullen">Elizabeth A. Gullen</name>
<affiliation wicri:level="1"><nlm:aff id="aff4">Department of Pharmacology, School of Medicine,<institution>Yale University</institution>
, New Haven, Connecticut 06520, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>, New Haven, Connecticut 06520</wicri:regionArea>
<wicri:noRegion>Connecticut 06520</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dutschman, Ginger E" sort="Dutschman, Ginger E" uniqKey="Dutschman G" first="Ginger E." last="Dutschman">Ginger E. Dutschman</name>
<affiliation wicri:level="1"><nlm:aff id="aff4">Department of Pharmacology, School of Medicine,<institution>Yale University</institution>
, New Haven, Connecticut 06520, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>, New Haven, Connecticut 06520</wicri:regionArea>
<wicri:noRegion>Connecticut 06520</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cheng, Yung Chi" sort="Cheng, Yung Chi" uniqKey="Cheng Y" first="Yung-Chi" last="Cheng">Yung-Chi Cheng</name>
<affiliation wicri:level="1"><nlm:aff id="aff4">Department of Pharmacology, School of Medicine,<institution>Yale University</institution>
, New Haven, Connecticut 06520, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>, New Haven, Connecticut 06520</wicri:regionArea>
<wicri:noRegion>Connecticut 06520</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Balzarini, Jan" sort="Balzarini, Jan" uniqKey="Balzarini J" first="Jan" last="Balzarini">Jan Balzarini</name>
<affiliation wicri:level="1"><nlm:aff id="aff5">Rega Institute for Medical Research,<institution>Katholieke Universiteit Leuven</institution>
, B-3000 Leuven, Belgium</nlm:aff>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>, B-3000 Leuven</wicri:regionArea>
<wicri:noRegion>B-3000 Leuven</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23795238</idno>
<idno type="pmc">3686520</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686520</idno>
<idno type="RBID">PMC:3686520</idno>
<idno type="doi">10.1021/ml2001054</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">000057</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000057</idno>
<idno type="wicri:Area/Pmc/Curation">000057</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000057</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000779</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000779</idno>
<idno type="wicri:Area/Ncbi/Merge">000387</idno>
<idno type="wicri:Area/Ncbi/Curation">000387</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000387</idno>
<idno type="wicri:doubleKey">1948-5875:2011:Haraguchi K:synthesis:of:ethynyl</idno>
<idno type="wicri:Area/Main/Merge">001374</idno>
<idno type="wicri:Area/Main/Curation">001372</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Synthesis of 4′-Ethynyl-2′-deoxy-4′-thioribonucleosides and Discovery of a Highly Potent and Less Toxic NRTI</title>
<author><name sortKey="Haraguchi, Kazuhiro" sort="Haraguchi, Kazuhiro" uniqKey="Haraguchi K" first="Kazuhiro" last="Haraguchi">Kazuhiro Haraguchi</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">School of Pharmacy,<institution>Showa University</institution>
, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shimada, Hisashi" sort="Shimada, Hisashi" uniqKey="Shimada H" first="Hisashi" last="Shimada">Hisashi Shimada</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">School of Pharmacy,<institution>Showa University</institution>
, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kimura, Keigo" sort="Kimura, Keigo" uniqKey="Kimura K" first="Keigo" last="Kimura">Keigo Kimura</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">School of Pharmacy,<institution>Showa University</institution>
, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Akutsu, Genta" sort="Akutsu, Genta" uniqKey="Akutsu G" first="Genta" last="Akutsu">Genta Akutsu</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">School of Pharmacy,<institution>Showa University</institution>
, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tanaka, Hiromichi" sort="Tanaka, Hiromichi" uniqKey="Tanaka H" first="Hiromichi" last="Tanaka">Hiromichi Tanaka</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">School of Pharmacy,<institution>Showa University</institution>
, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Abe, Hiroshi" sort="Abe, Hiroshi" uniqKey="Abe H" first="Hiroshi" last="Abe">Hiroshi Abe</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">RIKEN Advanced Science Institute,<institution>Nanomedical Engineering Laboratory</institution>
, 2-1, Hirosawa, Wako-shi, Saitama 351-0198, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, 2-1, Hirosawa, Wako-shi, Saitama 351-0198</wicri:regionArea>
<wicri:noRegion>Saitama 351-0198</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hamasaki, Takayuki" sort="Hamasaki, Takayuki" uniqKey="Hamasaki T" first="Takayuki" last="Hamasaki">Takayuki Hamasaki</name>
<affiliation wicri:level="1"><nlm:aff id="aff3">Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences,<institution>Kagoshima University</institution>
, Kagoshima 89-8544, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, Kagoshima 89-8544</wicri:regionArea>
<wicri:noRegion>Kagoshima 89-8544</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baba, Masanori" sort="Baba, Masanori" uniqKey="Baba M" first="Masanori" last="Baba">Masanori Baba</name>
<affiliation wicri:level="1"><nlm:aff id="aff3">Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences,<institution>Kagoshima University</institution>
, Kagoshima 89-8544, Japan</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>, Kagoshima 89-8544</wicri:regionArea>
<wicri:noRegion>Kagoshima 89-8544</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gullen, Elizabeth A" sort="Gullen, Elizabeth A" uniqKey="Gullen E" first="Elizabeth A." last="Gullen">Elizabeth A. Gullen</name>
<affiliation wicri:level="1"><nlm:aff id="aff4">Department of Pharmacology, School of Medicine,<institution>Yale University</institution>
, New Haven, Connecticut 06520, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>, New Haven, Connecticut 06520</wicri:regionArea>
<wicri:noRegion>Connecticut 06520</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dutschman, Ginger E" sort="Dutschman, Ginger E" uniqKey="Dutschman G" first="Ginger E." last="Dutschman">Ginger E. Dutschman</name>
<affiliation wicri:level="1"><nlm:aff id="aff4">Department of Pharmacology, School of Medicine,<institution>Yale University</institution>
, New Haven, Connecticut 06520, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>, New Haven, Connecticut 06520</wicri:regionArea>
<wicri:noRegion>Connecticut 06520</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cheng, Yung Chi" sort="Cheng, Yung Chi" uniqKey="Cheng Y" first="Yung-Chi" last="Cheng">Yung-Chi Cheng</name>
<affiliation wicri:level="1"><nlm:aff id="aff4">Department of Pharmacology, School of Medicine,<institution>Yale University</institution>
, New Haven, Connecticut 06520, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>, New Haven, Connecticut 06520</wicri:regionArea>
<wicri:noRegion>Connecticut 06520</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Balzarini, Jan" sort="Balzarini, Jan" uniqKey="Balzarini J" first="Jan" last="Balzarini">Jan Balzarini</name>
<affiliation wicri:level="1"><nlm:aff id="aff5">Rega Institute for Medical Research,<institution>Katholieke Universiteit Leuven</institution>
, B-3000 Leuven, Belgium</nlm:aff>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>, B-3000 Leuven</wicri:regionArea>
<wicri:noRegion>B-3000 Leuven</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">ACS Medicinal Chemistry Letters</title>
<idno type="ISSN">1948-5875</idno>
<idno type="eISSN">1948-5875</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p content-type="toc-graphic"><graphic xlink:href="ml-2011-001054_0014" id="ab-tgr1"></graphic>
</p>
<p>The synthesis of 4′-ethynyl-2′-deoxy-4′-thioribonucleosides was carried out utilizing an electrophilic glycosidation in which 4-ethynyl-4-thiofuranoid glycal <bold>16</bold>
served as a glycosyl donor. Electrophilic glycosidation between <bold>16</bold>
and the silylated nucleobases (<italic>N</italic>
<sup>4</sup>
-acetylcytosine, <italic>N</italic>
<sup>6</sup>
-benzoyladenine, and <italic>N</italic>
<sup>2</sup>
-acetyl-<italic>O</italic>
<sup>6</sup>
-diphenylcarbamoylguanine) was carried out in the presence of <italic>N</italic>
-iodosuccinimide (NIS), leading to the exclusive formation of the desired β-anomers <bold>29</bold>
, <bold>33</bold>
, and <bold>36</bold>
. Anti-HIV studies demonstrated that these 4′-thio nucleosides were less cytotoxic to T-lymphocyte (i.e., MT-4 cells) than the corresponding 4′-ethynyl derivatives of 2′-deoxycytidine (<bold>44</bold>
), 2′-deoxyadenosine (<bold>45</bold>
), and 2′-deoxyguanosine (<bold>46</bold>
). Comparison of the selectivity indices (SI) was made between 4′-thionucleosides (<bold>32</bold>
, <bold>41</bold>
, and <bold>43</bold>
) and the corresponding 4′-oxygen analogues <bold>44</bold>
-<bold>46</bold>
by using the reported CC<sub>50</sub>
and EC<sub>50</sub>
values. In the case of cytosine and adenine nucleosides, comparable SI values were obtained as follows: <bold>32</bold>
(545) and <bold>44</bold>
(458); <bold>41</bold>
(>230) and <bold>45</bold>
(1630). In contrast, 4′-ethynyl-2′-deoxy-4′-thioguanosine <bold>43</bold>
was found to possess a SI value of >18200, which is 20 times better than that of <bold>46</bold>
(933).</p>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001372 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001372 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= Main |étape= Curation |type= RBID |clé= PMC:3686520 |texte= Synthesis of 4′-Ethynyl-2′-deoxy-4′-thioribonucleosides and Discovery of a Highly Potent and Less Toxic NRTI }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:23795238" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a CovidV2
This area was generated with Dilib version V0.6.33. |